Michael H. Davidson, MD joins the International Board of Medical Affairs Officers with the Accreditation Council for Medical Affairs (ACMA)

NEW YORK, Aug. 11, 2017 /PRNewswire-USNewswire/ -- The Accreditation Council for Medical Affairs (ACMA), a leading organization within medical affairs in the pharmaceutical industry is pleased to announce the addition of Michael H. Davidson, MD to the newly formed International Board of Medical Affairs Officers. 

For more information about the ACMA, please visit www.medicalaffairsspecialist.org. 
Connect with us on LinkedIn or Follow us on Facebook.

"Dr. Davidson brings a wealth of knowledge and expertise to the ACMA Advisory Board," said Dr. William A. Soliman, Executive Chair of the ACMA.  "Dr. Davidson is recognized as an international thought leader within preventive cardiology.  He has participated in over 1000 clinical trials and has published over 250 articles, being named one of "The Best Doctors in America" for the past 10 years." 

"I am happy to be associated with an organization like the ACMA that exemplifies the highest level of distinction within medical affairs for the pharmaceutical industry worldwide," said Dr. Davidson. "Providing independent credentialing in medical affairs within the pharmaceutical industry is critical to establishing a standard of excellence among medical affairs professionals which translates into more reliable information to physicians and improved patient care."

In addition to Dr. Michael Davidson, the ACMA International Board is comprised of key thought leaders such as Dr. Wajahat Mehal, MD, PhD, Director of Digestive Diseases at Yale University School of Medicine, Dr. Charles Schmidt, MD from Santa Casa Medical School in Sao Paulo, Brazil and Dr. Julio Casoy, MD, a former executive director within the pharmaceutical industry.

About the ACMA:

The Accreditation Council for Medical Affairs (ACMA) provides accredited and certified programs in medical affairs. The Board Certified Medical Affairs Specialist Program (BCMAS) is the most comprehensive medical affairs program in the world and is the industry standard. To be eligible for the program, candidates must possess a PharmD, MD, or PhD.  Additionally, a board examination is required to successfully complete the program. 

Contact: Dr. Suzanne Soliman, Chief Academic Officer ACMA, 855-255-7137

SOURCE Accreditation Council for Medical Affairs

Related Links

https://www.medicalaffairsspecialist.org